Infective endocarditis: Difference between revisions
From IDWiki
m (Aidan moved page Infective Infective endocarditis (IE) to Infective endocarditis without leaving a redirect) |
No edit summary |
||
| Line 1: | Line 1: | ||
| ⚫ | |||
| − | = Infective endocarditis (IE) = |
||
| − | |||
| − | See also [IDSA: IE Management 2015](/Infectious Diseases/IDSA Guidelines/IE Management 2015/IE Management 2015.md) |
||
| − | |||
| ⚫ | |||
* Infection of heart valves |
* Infection of heart valves |
||
| − | + | = Organisms = |
|
| − | * ''Staphylococcus aureus'' |
+ | * ''[[Staphylococcus aureus]]'' |
| − | * Viridans group streptococci |
+ | * [[Viridans group streptococci]] |
| − | * Coagulase-negative staphylococci |
+ | * [[Coagulase-negative staphylococci]] |
* Other streptococci |
* Other streptococci |
||
| − | * Enterococci |
+ | * [[Enterococci]] |
| − | * HACEK group |
+ | * [[HACEK group]] |
| − | * Fungi |
+ | * [[Fungi]] |
| − | + | = Presentation = |
|
| − | * [Modified Duke criteria] |
+ | * [[Modified Duke criteria]] |
* IVDU: Viridans group streptococci and ''Pseudomonas aeroginosa'' |
* IVDU: Viridans group streptococci and ''Pseudomonas aeroginosa'' |
||
* Colon cancer: ''Streptococcus bovis'' and ''Clostridium septicum'' |
* Colon cancer: ''Streptococcus bovis'' and ''Clostridium septicum'' |
||
| − | + | = Treatment = |
|
* MSSA native valve endocarditis |
* MSSA native valve endocarditis |
||
| − | ** Cloxacillin or cefazolin |
+ | ** [[Cloxacillin]] or [[cefazolin]] |
| + | ** OR [[Vancomycin]]/[[Daptomycin]] |
||
| − | ** OR vanco/dapto |
||
* MSSA prosthetic valve endocarditis |
* MSSA prosthetic valve endocarditis |
||
| − | ** |
+ | ** [[Cloxacillin]] PLUS [[rifampin]] PLUS 2 weeks of [[gentamicin]] |
| − | ** OR |
+ | ** OR [[Vancomycin]]/[[Daptomycin]], other things |
| − | + | * 6 weeks |
|
| + | |||
| + | [[Category:Cardiac infections]] |
||
Revision as of 23:32, 14 August 2019
Diagnosis
- Infection of heart valves
Organisms
- Staphylococcus aureus
- Viridans group streptococci
- Coagulase-negative staphylococci
- Other streptococci
- Enterococci
- HACEK group
- Fungi
Presentation
- Modified Duke criteria
- IVDU: Viridans group streptococci and Pseudomonas aeroginosa
- Colon cancer: Streptococcus bovis and Clostridium septicum
Treatment
- MSSA native valve endocarditis
- MSSA prosthetic valve endocarditis
- Cloxacillin PLUS rifampin PLUS 2 weeks of gentamicin
- OR Vancomycin/Daptomycin, other things
- 6 weeks
References
- ^ Kasper Iversen, Nikolaj Ihlemann, Sabine U. Gill, Trine Madsen, Hanne Elming, Kaare T. Jensen, Niels E. Bruun, Dan E. Høfsten, Kurt Fursted, Jens J. Christensen, Martin Schultz, Christine F. Klein, Emil L. Fosbøll, Flemming Rosenvinge, Henrik C. Schønheyder, Lars Køber, Christian Torp-Pedersen, Jannik Helweg-Larsen, Niels Tønder, Claus Moser, Henning Bundgaard. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis. New England Journal of Medicine. 2019;380(5):415-424. doi:10.1056/nejmoa1808312.
- ^ John A Wildenthal, Andrew Atkinson, Sophia Lewis, Sena Sayood, Nathanial S Nolan, Nicolo L Cabrera, Jonas Marschall, Michael J Durkin, Laura R Marks. Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs. Clinical Infectious Diseases. 2022;76(3):487-496. doi:10.1093/cid/ciac714.
- ^ Sarah Freling, Noah Wald-Dickler, Josh Banerjee, Catherine P Canamar, Soodtida Tangpraphaphorn, Dara Bruce, Kusha Davar, Fernando Dominguez, Daniel Norwitz, Ganesh Krishnamurthi, Lilian Fung, Ashley Guanzon, Emi Minejima, Michael Spellberg, Catherine Spellberg, Rachel Baden, Paul Holtom, Brad Spellberg. Real-World Application of Oral Therapy for Infective Endocarditis: A Multicenter, Retrospective, Cohort Study. Clinical Infectious Diseases. 2023;77(5):672-679. doi:10.1093/cid/ciad119.
